With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Mechanisms of BRAF Activation in KIAA1549-BRAF Mutant pLGGs||Broad Institute / Sean Misek, PhD||Young Investigator Grants||2023||Massachusetts|
|Synthetic Gene Expression Regulatory Switches (SynGERS) for Improved CAR T Cell Function in Pediatric Solid Tumors||Baylor College of Medicine / Leidy Diana Caraballo Galva, PhD||Young Investigator Grants||2023||Texas|
|The Impact of the Intestinal Microbiome on Sarcoma Metastasis||Albert Einstein College of Medicine / David Loeb, MD, PhD||Innovation Grants||2023||New York|
|Development of RADARS-based Therapy to Treat Fusion Molecule Driven Pediatric Malignancies||Boston Children's Hospital / Alan B. Cantor, MD, PhD||Innovation Grants||2023||Massachusetts|
|Elucidating the Roles of Aneuploidy in Down Syndrome-Associated Leukemia||Boston Children's Hospital / Chun-Chin Chen, PhD||Young Investigator Grants||2023||Massachusetts|
|CDK12 Links Radiation Response to PARPi Sensitivity in Pediatric Glioma||University of Colorado Denver_ Anschutz Medical Campus / Nathan Dahl, MD||Innovation Grants||2023||Colorado|
|Characterizing the Developmental Context of Pediatric Leukemia||Icahn School of Medicine at Mount Sinai / Elvin Wagenblast, PhD||'A' Award Grants||2022||New York|
|Exploiting glypican diversity in neuroblastoma plasticity with bicistronic CAR T cell targeting||Children's Hospital of Philadelphia / Kristopher Bosse, MD||'A' Award Grants||2022||Pennsylvania|
|Enhancing TKI Therapy in Ph-Like Leukemia||The Regents of the University of California, Irvine / David Fruman, PhD||Reach Grants||2022||California|
|Developing Novel Transcription Factor PROTACs to Disrupt the HMGA1 Epigenome in Relapsed Leukemia||Icahn School of Medicine at Mount Sinai / Linda Resar, MD and Jian Jin, PhD||Innovation Grants||2022||New York|